1,2,3,4-tetrahydroisoquinoline derivatives, preparations thereof and uses thereof

Details for Australian Patent Application No. 2004303736 (hide)

Owner AstraZeneca AB

Inventors Janssen, Christian; Le, Phuc Van; Jenkins, Ian; Quinn, Ron; Ripper, Justin

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2004303736

PCT Pub. Number WO2005/061484

Priority 0303542-5 22.12.03 SE

Filing date 20 December 2004

Wipo publication date 7 July 2005

Acceptance publication date 15 May 2008

International Classifications

A61K 31/4725 (2006.01)

A61K 31/4741 (2006.01)

A61P 25/04 (2006.01) Drugs for disorders of the nervous system

A61P 25/22 (2006.01) Drugs for disorders of the nervous system

C07D 401/06 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 405/06 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 409/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 417/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 491/056 (2006.01) Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

Event Publications

13 July 2006 PCT application entered the National Phase

  PCT publication WO2005/061484 Priority application(s): WO2005/061484

15 May 2008 Application Accepted

  Published as AU-B-2004303736

11 September 2008 Standard Patent Sealed

15 July 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004303737-Nicotinic acetylcholine receptor ligands

2004303735-Novel tricyclic spiroderivatives as modulators of chemokine receptor activity